{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:13:39Z","timestamp":1788873219730,"version":"build-2803163510"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"John and Anna Belfer Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03927-8","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:17:09Z","timestamp":1782195429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The complement system in Alzheimer\u2019s disease: evaluating biomarker potential in a complex neuroimmune context"],"prefix":"10.1186","volume":"23","author":[{"given":"Heli","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg T.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5111-3978","authenticated-orcid":false,"given":"Markus J.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"3927_CR1","doi-asserted-by":"publisher","unstructured":"Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer\u2019s Disease: Causes and Treatment. Molecules. 2020;25(24):5789. https:\/\/doi.org\/10.3390\/molecules25245789","DOI":"10.3390\/molecules25245789"},{"issue":"3","key":"3927_CR2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/neurolint15030054","volume":"15","author":"Nicholas Doher 1 VD","year":"2023","unstructured":"Nicholas Doher 1 VD. Shino Magaki 3, Ryan A Townley 4 5, Mohammad Haeri 2 5, Harry V Vinters Illustrated Neuropathologic Diagnosis of Alzheimer\u2019s Disease. Neurol Int. 2023;15(3):857\u201367.","journal-title":"Neurol Int"},{"issue":"1","key":"3927_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","volume":"19","author":"JA Trejo-Lopez","year":"2022","unstructured":"Trejo-Lopez JA, Yachnis AT, Prokop S. Neuropathology of Alzheimer\u2019s Disease. Neurotherapeutics. 2022;19(1):173\u201385.","journal-title":"Neurotherapeutics"},{"key":"3927_CR4","doi-asserted-by":"crossref","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimer\u2019s & Dementia. 2024;20(8):5143-69.","DOI":"10.1002\/alz.13859"},{"issue":"1","key":"3927_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","volume":"15","author":"B Dubois","year":"2023","unstructured":"Dubois B, von Arnim CAF, Burnie N, Bozeat S, Cummings J. Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants. Alzheimers Res Ther. 2023;15(1):175.","journal-title":"Alzheimers Res Ther"},{"key":"3927_CR6","doi-asserted-by":"publisher","unstructured":"Kobayashi G, Hirata K, Ono M, Kasuga K, Takado Y. The 2024 NIA-AA biological definition of Alzheimer\u2019s disease: linking biomarkers to clinical practice. Front Dement. 2026;Volume 5\u20132026. https:\/\/doi.org\/10.3389\/frdem.2026.1736297","DOI":"10.3389\/frdem.2026.1736297"},{"issue":"3","key":"3927_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/brain\/awaf346","volume":"149","author":"DR Johnson","year":"2026","unstructured":"Johnson DR, Wiste HJ, Lowe V, Schwarz CG, Knopman DS, Vemuri P, et al. Staging Alzheimer\u2019s disease through amyloid and tau PET. Brain. 2026;149(3):1023\u201334.","journal-title":"Brain"},{"issue":"5","key":"3927_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","volume":"25","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, et al. Neuroinflammation in Alzheimer disease. Nat Rev Immunol. 2025;25(5):321\u201352.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"3927_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41582-022-00642-9","volume":"18","author":"T G\u00f3mez-Isla","year":"2022","unstructured":"G\u00f3mez-Isla T, Frosch MP. Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes. Nat Reviews Neurol. 2022;18(6):323\u201332.","journal-title":"Nat Reviews Neurol"},{"key":"3927_CR10","doi-asserted-by":"publisher","first-page":"102736","DOI":"10.1016\/j.arr.2025.102736","volume":"108","author":"A Meher Rijwana","year":"2025","unstructured":"Meher Rijwana A, Pankaj Ghritakousik U, Abdul H, Kunal B, Nongmaithem Randhoni C, Dibyajyoti D, et al. Advanced biomarkers: Beyond amyloid and tau: Emerging non-traditional biomarkers for alzheimer`s diagnosis and progression. Ageing Res Rev. 2025;108:102736.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"3927_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","volume":"13","author":"C Cicognola","year":"2021","unstructured":"Cicognola C, Janelidze S, Hertze J, Zetterberg H, Blennow K, Mattsson-Carlgren N, et al. Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment. Alzheimers Res Ther. 2021;13(1):68.","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"3927_CR12","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/acn3.51109","volume":"7","author":"JA Pillai","year":"2020","unstructured":"Pillai JA, Bena J, Bebek G, Bekris LM, Bonner-Jackson A, Kou L, et al. Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2020;7(7):1225\u201339.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"3927_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3233\/JAD-230199","volume":"95","author":"Y Wu","year":"2023","unstructured":"Wu Y, Eisel ULM. Microglia-Astrocyte Communication in Alzheimer\u2019s Disease. J Alzheimers Dis. 2023;95(3):785\u2013803.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"3927_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12974-022-02383-4","volume":"19","author":"C Mu\u00f1oz-Castro","year":"2022","unstructured":"Mu\u00f1oz-Castro C, Noori A, Magdamo CG, Li Z, Marks JD, Frosch MP, et al. Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer\u2019s disease. J Neuroinflamm. 2022;19(1):30.","journal-title":"J Neuroinflamm"},{"key":"3927_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/ITT.S455881","volume":"13","author":"H Yan","year":"2024","unstructured":"Yan H, Wang W, Cui T, Shao Y, Li M, Fang L, et al. Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer\u2019s Disease. Immunotargets Ther. 2024;13:287\u2013304.","journal-title":"Immunotargets Ther"},{"issue":"6286","key":"3927_CR16","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712\u20136.","journal-title":"Science"},{"issue":"12","key":"3927_CR17","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.3390\/ijms25126295","volume":"25","author":"Y Park","year":"2024","unstructured":"Park Y, KC N, Paneque A, Cole PD. Tau, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain as Brain Protein Biomarkers in Cerebrospinal Fluid and Blood for Diagnosis of Neurobiological Diseases. Int J Mol Sci. 2024;25(12):6295.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3927_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","volume":"20","author":"M Khalil","year":"2024","unstructured":"Khalil M, Teunissen CE, Lehmann S, Otto M, Piehl F, Ziemssen T, et al. Neurofilaments as biomarkers in neurological disorders \u2014 towards clinical application. Nat Reviews Neurol. 2024;20(5):269\u201387.","journal-title":"Nat Reviews Neurol"},{"issue":"3","key":"3927_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/brainsci14030272","volume":"14","author":"C Gallingani","year":"2024","unstructured":"Gallingani C, Carbone C, Tondelli M, Zamboni G. Neurofilaments Light Chain in Neurodegenerative Dementias: A Review of Imaging Correlates. Brain Sci. 2024;14(3):272.","journal-title":"Brain Sci"},{"key":"3927_CR20","doi-asserted-by":"crossref","unstructured":"Forgrave LM, Ma M, Best JR, DeMarco ML. The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer\u2019s disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2019;11:730\u201343.","DOI":"10.1016\/j.dadm.2019.08.009"},{"issue":"1","key":"3927_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13024-025-00846-9","volume":"20","author":"W Youn","year":"2025","unstructured":"Youn W, Yun M, Lee CJ, Sch\u00f6ll M. Cautions on utilizing plasma GFAP level as a biomarker for reactive astrocytes in neurodegenerative diseases. Mol Neurodegeneration. 2025;20(1):54.","journal-title":"Mol Neurodegeneration"},{"issue":"1","key":"3927_CR22","doi-asserted-by":"publisher","first-page":"e16226","DOI":"10.1111\/jnc.16226","volume":"169","author":"D Gogishvili","year":"2025","unstructured":"Gogishvili D, Honey MIJ, Verberk IMW, Vermunt L, Hol EM, Teunissen CE, et al. The GFAP proteoform puzzle: How to advance GFAP as a fluid biomarker in neurological diseases. J Neurochem. 2025;169(1):e16226.","journal-title":"J Neurochem"},{"key":"3927_CR23","doi-asserted-by":"publisher","unstructured":"Aranda-Abreu GE, Rojas-Dur\u00e1n F, Hern\u00e1ndez-Aguilar ME, Herrera-Covarrubias D, Tlapa-Monge LR, Mestizo-Guti\u00e9rrez SL. Alzheimer\u2019s Disease as a Disorder of Neuroimmune Dysregulation. Neurol Int. 2026;18(2):37. https:\/\/doi.org\/10.3390\/neurolint18020037","DOI":"10.3390\/neurolint18020037"},{"issue":"2","key":"3927_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/WCO.0000000000001462","volume":"39","author":"M Bluma","year":"2026","unstructured":"Bluma M, Chiotis K, Nordberg A. Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer\u2019s disease and beyond. Curr Opin Neurol. 2026;39(2):176\u201384.","journal-title":"Curr Opin Neurol"},{"issue":"16","key":"3927_CR25","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.3390\/ijms26167792","volume":"26","author":"R Di Lorenzo","year":"2025","unstructured":"Di Lorenzo R, Zecca C, Chimienti G, Latronico T, Liuzzi GM, Pesce V, et al. Reliable new biomarkers of mitochondrial oxidative stress and neuroinflammation in cerebrospinal fluid and plasma from Alzheimer\u2019s disease patients: A pilot study. Int J Mol Sci. 2025;26(16):7792.","journal-title":"Int J Mol Sci"},{"key":"3927_CR26","doi-asserted-by":"publisher","unstructured":"Wang Y-Y, Zhang M, Chen S-J, Miao W, Wang Z-X, Zhou Y-J et al. Neuroinflammation-mediated YKL-40 correlates with tau pathology and predicts longitudinal cognitive impairment and brain atrophy in Alzheimer\u2019s disease, with hypertensive dependency. Front Aging Neurosci. 2025;Volume 17\u20132025:1630022. https:\/\/doi.org\/10.3389\/fnagi.2025.1630022","DOI":"10.3389\/fnagi.2025.1630022"},{"issue":"8","key":"3927_CR27","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.celrep.2019.07.060","volume":"28","author":"T Wu","year":"2019","unstructured":"Wu T, Dejanovic B, Gandham VD, Gogineni A, Edmonds R, Schauer S, et al. Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell Rep. 2019;28(8):2111\u201323. e6.","journal-title":"Cell Rep"},{"issue":"5","key":"3927_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41582-025-01073-y","volume":"21","author":"AJ Tenner","year":"2025","unstructured":"Tenner AJ, Petrisko TJ. Knowing the enemy: strategic targeting of complement to treat Alzheimer disease. Nat Reviews Neurol. 2025;21(5):250\u201364.","journal-title":"Nat Reviews Neurol"},{"issue":"14","key":"3927_CR29","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.molimm.2011.04.003","volume":"48","author":"R Veerhuis","year":"2011","unstructured":"Veerhuis R, Nielsen HM, Tenner AJ. Complement in the brain. Mol Immunol. 2011;48(14):1592\u2013603.","journal-title":"Mol Immunol"},{"key":"3927_CR30","doi-asserted-by":"publisher","unstructured":"Freiwald T, Afzali B. The secret life of complement: challenges and opportunities in exploring functions of the complosome in disease. J Clin Investig. 2025;135(12):e188350. https:\/\/doi.org\/10.1172\/JCI188350","DOI":"10.1172\/JCI188350"},{"issue":"33","key":"3927_CR31","doi-asserted-by":"publisher","first-page":"13460","DOI":"10.1523\/JNEUROSCI.1333-13.2013","volume":"33","author":"AH Stephan","year":"2013","unstructured":"Stephan AH, Madison DV, Mateos JM, Fraser DA, Lovelett EA, Coutellier L, et al. A dramatic increase of C1q protein in the CNS during normal aging. J Neurosci. 2013;33(33):13460\u201374.","journal-title":"J Neurosci"},{"issue":"1","key":"3927_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41398-025-03458-5","volume":"15","author":"F Guo","year":"2025","unstructured":"Guo F, Sheng Z-H, Fu Y, Wang Z-B, Xue R-J, Tan L, et al. Complement C1q is associated with neuroinflammation and mediates the association between amyloid-\u03b2 and tau pathology in Alzheimer\u2019s disease. Translational Psychiatry. 2025;15(1):247.","journal-title":"Translational Psychiatry"},{"issue":"1","key":"3927_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/exnr.1996.0043","volume":"138","author":"A Afagh","year":"1996","unstructured":"Afagh A, Cummings BJ, Cribbs DH, Cotman CW, Tenner AJ. Localization and Cell Association of C1q in Alzheimer\u2019s Disease Brain. Exp Neurol. 1996;138(1):22\u201332.","journal-title":"Exp Neurol"},{"issue":"7638","key":"3927_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"12","key":"3927_CR35","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"3927_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/156720511794604589","volume":"8","author":"R Veerhuis","year":"2011","unstructured":"Veerhuis R. Histological and direct evidence for the role of complement in the neuroinflammation of AD. Curr Alzheimer Res. 2011;8(1):34\u201358.","journal-title":"Curr Alzheimer Res"},{"issue":"24","key":"3927_CR37","doi-asserted-by":"publisher","first-page":"13647","DOI":"10.3390\/ijms222413647","volume":"22","author":"A Shah","year":"2021","unstructured":"Shah A, Kishore U, Shastri A. Complement System in Alzheimer\u2019s Disease. Int J Mol Sci. 2021;22(24):13647.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3927_CR38","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3390\/biom15081179","volume":"15","author":"I Jov\u010devska","year":"2025","unstructured":"Jov\u010devska I, Videti\u010d Paska A, Kouter K. Complement Cascades and Brain Disorders. Biomolecules. 2025;15(8):1179.","journal-title":"Biomolecules"},{"issue":"5","key":"3927_CR39","doi-asserted-by":"publisher","first-page":"100079","DOI":"10.1016\/j.pharmr.2025.100079","volume":"77","author":"XX Li","year":"2025","unstructured":"Li XX, Woodruff TM. The complement system: Biology, pathology, and therapeutic interventions. Pharmacol Rev. 2025;77(5):100079.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"3927_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12026-011-8239-5","volume":"51","author":"CA Tegla","year":"2011","unstructured":"Tegla CA, Cudrici C, Patel S, Trippe R III, Rus V, Niculescu F, et al. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res. 2011;51(1):45\u201360.","journal-title":"Immunol Res"},{"key":"3927_CR41","first-page":"3","volume-title":"Neurobiology of Alzheimer\u2019s Disease","author":"N Daskoulidou","year":"2025","unstructured":"Daskoulidou N, Carpanini SM, Zelek WM, Morgan BP. Involvement of Complement in Alzheimer\u2019s Disease: From Genetics Through Pathology to Therapeutic Strategies. In: Kidd EJ, Newhouse PA, editors. Neurobiology of Alzheimer\u2019s Disease. Cham: Springer Nature Switzerland; 2025. pp. 3\u201324."},{"issue":"1","key":"3927_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-025-00916-y","volume":"21","author":"M-T Papavergi","year":"2025","unstructured":"Papavergi M-T, Bathini P, Singh B, Lemere CA. The complement cascade in Alzheimer\u2019s disease: modern implications of an ancient immune protagonist. Mol Neurodegeneration. 2025;21(1):5.","journal-title":"Mol Neurodegeneration"},{"issue":"2","key":"3927_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cei.12952","volume":"188","author":"R Lubbers","year":"2017","unstructured":"Lubbers R, Van Essen M, Van Kooten C, Trouw L. Production of complement components by cells of the immune system. Clin Experimental Immunol. 2017;188(2):183\u201394.","journal-title":"Clin Experimental Immunol"},{"key":"3927_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molimm.2018.06.264","volume":"102","author":"AJ Tenner","year":"2018","unstructured":"Tenner AJ, Stevens B, Woodruff TM. New tricks for an ancient system: Physiological and pathological roles of complement in the CNS. Mol Immunol. 2018;102:3\u201313.","journal-title":"Mol Immunol"},{"issue":"2","key":"3927_CR45","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0006-8993(97)00849-4","volume":"769","author":"K Terai","year":"1997","unstructured":"Terai K, Walker DG, McGeer EG, McGeer PL. Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res. 1997;769(2):385\u201390.","journal-title":"Brain Res"},{"issue":"1","key":"3927_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0006-8993(98)00811-7","volume":"809","author":"DG Walker","year":"1998","unstructured":"Walker DG, Kim SU, McGeer PL. Expression of complement C4 and C9 genes by human astrocytes. Brain Res. 1998;809(1):31\u20138.","journal-title":"Brain Res"},{"issue":"4","key":"3927_CR47","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jnr.490400407","volume":"40","author":"D Walker","year":"1995","unstructured":"Walker D, Kim S, McGeer P. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J Neurosci Res. 1995;40(4):478\u201393.","journal-title":"J Neurosci Res"},{"issue":"6","key":"3927_CR48","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1042\/CS20230513","volume":"138","author":"J Nimmo","year":"2024","unstructured":"Nimmo J, Byrne RAJ, Daskoulidou N, Watkins LM, Carpanini SM, Zelek WM, et al. The complement system in neurodegenerative diseases. Clin Sci (Lond). 2024;138(6):387\u2013412.","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"3927_CR49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/glia.20219","volume":"52","author":"R Cassiani-Ingoni","year":"2005","unstructured":"Cassiani-Ingoni R, Greenstone HL, Donati D, Fogdell-Hahn A, Martinelli E, Refai D, et al. CD46 on glial cells can function as a receptor for viral glycoprotein-mediated cell\u2013cell fusion. Glia. 2005;52(3):252\u20138.","journal-title":"Glia"},{"issue":"1","key":"3927_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12974-019-1448-x","volume":"16","author":"L Tradtrantip","year":"2019","unstructured":"Tradtrantip L, Duan T, Yeaman MR, Verkman AS. CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica. J Neuroinflamm. 2019;16(1):57.","journal-title":"J Neuroinflamm"},{"issue":"4","key":"3927_CR51","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0169-328X(93)90098-A","volume":"18","author":"DL Gordon","year":"1993","unstructured":"Gordon DL, Sadlon T, Hefford C, Adrian D. Expression of CD59, a regulator of the membrane attack complex of complement, on human astrocytes. Mol Brain Res. 1993;18(4):335\u20138.","journal-title":"Mol Brain Res"},{"key":"3927_CR52","doi-asserted-by":"crossref","unstructured":"Liu Z, Chao J, Wang C, Sun G, Roeth D, Liu W et al. Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model. Cell Rep. 2023;42(8).","DOI":"10.1016\/j.celrep.2023.112841"},{"issue":"6","key":"3927_CR53","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/glia.24355","volume":"71","author":"N Daskoulidou","year":"2023","unstructured":"Daskoulidou N, Shaw B, Torvell M, Watkins L, Cope EL, Carpanini SM, et al. Complement receptor 1 is expressed on brain cells and in the human brain. Glia. 2023;71(6):1522\u201335.","journal-title":"Glia"},{"issue":"3","key":"3927_CR54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO;2-M","volume":"26","author":"N Davoust","year":"1999","unstructured":"Davoust N, Jones J, Stahel PF, Ames RS, Barnum SR. Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells. Glia. 1999;26(3):201\u201311.","journal-title":"Glia"},{"issue":"1","key":"3927_CR55","first-page":"31","volume":"150","author":"P Gasque","year":"1997","unstructured":"Gasque P, Singhrao SK, Neal JW, G\u00f6tze O, Morgan BP. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol. 1997;150(1):31.","journal-title":"Am J Pathol"},{"issue":"5","key":"3927_CR56","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/j.1471-4159.2008.05558.x","volume":"106","author":"J Zhou","year":"2008","unstructured":"Zhou J, Fonseca MI, Pisalyaput K, Tenner AJ. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer\u2019s disease. J Neurochem. 2008;106(5):2080\u201392.","journal-title":"J Neurochem"},{"issue":"4","key":"3927_CR57","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s11064-022-03743-5","volume":"48","author":"M Pekna","year":"2023","unstructured":"Pekna M, Siqin S, de Pablo Y, Stokowska A, Torinsson Naluai \u00c5, Pekny M. Astrocyte Responses to Complement Peptide C3a are Highly Context-Dependent. Neurochem Res. 2023;48(4):1233\u201341.","journal-title":"Neurochem Res"},{"issue":"1","key":"3927_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40478-025-02090-0","volume":"14","author":"AL Teles e Silva","year":"2025","unstructured":"Teles e Silva AL, Prado de Oliveira PH, Yokota-Moreno BY, da Silva Fausto J, Avila JP, Nakaya HI, et al. Complement pathway dysregulation and astrocyte alterations in Down syndrome: evidence from postmortem brain tissue and iPSC-derived astrocytes. Acta Neuropathol Commun. 2025;14(1):15.","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"3927_CR59","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.4049\/jimmunol.154.9.4726","volume":"154","author":"P Gasque","year":"1995","unstructured":"Gasque P, Fontaine M, Morgan BP. Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J Immunol. 1995;154(9):4726\u201333.","journal-title":"J Immunol"},{"key":"3927_CR60","doi-asserted-by":"crossref","unstructured":"Fonseca MI, Shu-Hui C, Hernandez MX, Fang MJ, Modarresi L, Selvan P et al. Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain. J Neuroinflamm. 2017;14.","DOI":"10.1186\/s12974-017-0814-9"},{"issue":"4","key":"3927_CR61","first-page":"542","volume":"82","author":"C Vedeler","year":"1994","unstructured":"Vedeler C, Ulvestad E, Bj\u00f8rge L, Conti G, Williams K, M\u00f8rk S, et al. The expression of CD59 in normal human nervous tissue. Immunology. 1994;82(4):542.","journal-title":"Immunology"},{"issue":"7","key":"3927_CR62","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/intimm\/12.7.1015","volume":"12","author":"A Thomas","year":"2000","unstructured":"Thomas A, Gasque P, Vaudry D, Gonzalez B, Fontaine M. Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol. 2000;12(7):1015\u201323.","journal-title":"Int Immunol"},{"issue":"2","key":"3927_CR63","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0006-8993(97)00850-0","volume":"769","author":"Y Shen","year":"1997","unstructured":"Shen Y, Li R, McGeer EG, McGeer PL. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 1997;769(2):391\u20135.","journal-title":"Brain Res"},{"issue":"3","key":"3927_CR64","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1046\/j.1365-2567.1996.d01-756.x","volume":"89","author":"P Gasque","year":"1996","unstructured":"Gasque P, Morgan B. Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes. Immunology. 1996;89(3):338\u201347.","journal-title":"Immunology"},{"issue":"4","key":"3927_CR65","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/glia.10234","volume":"42","author":"M Hosokawa","year":"2003","unstructured":"Hosokawa M, Klegeris A, Maguire J, McGeer PL. Expression of complement messenger RNAs and proteins by human oligodendroglial cells. Glia. 2003;42(4):417\u201323.","journal-title":"Glia"},{"issue":"6","key":"3927_CR66","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00281-021-00892-7","volume":"43","author":"RB Pouw","year":"2021","unstructured":"Pouw RB, Ricklin D. Tipping the balance: intricate roles of the complement system in disease and therapy. Semin Immunopathol. 2021;43(6):757\u201371.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"3927_CR67","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ajpath.2011.01.006","volume":"178","author":"Y Wang","year":"2011","unstructured":"Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, et al. Complement 3 and factor h in human cerebrospinal fluid in Parkinson\u2019s disease, Alzheimer\u2019s disease, and multiple-system atrophy. Am J Pathol. 2011;178(4):1509\u201316.","journal-title":"Am J Pathol"},{"issue":"1","key":"3927_CR68","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1038\/s41467-024-51163-6","volume":"15","author":"ND Schartz","year":"2024","unstructured":"Schartz ND, Liang HY, Carvalho K, Chu S-H, Mendoza-Arvilla A, Petrisko TJ, et al. C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u2019s disease mouse model. Nat Commun. 2024;15(1):7028.","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"3927_CR69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0006-8993(94)91640-3","volume":"645","author":"S Itagaki","year":"1994","unstructured":"Itagaki S, Akiyama H, Saito H, McGeer PL. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer\u2019s disease. Brain Res. 1994;645(1\u20132):78\u201384.","journal-title":"Brain Res"},{"issue":"9","key":"3927_CR70","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1016\/j.biopsych.2020.02.360","volume":"87","author":"M Demers","year":"2020","unstructured":"Demers M, D\u2019Aiuto L, Wood J, Nimgaonkar V, Zheng W. A Human iPSC-Based Model of the Complement System in CNS Cells. Biol Psychiatry. 2020;87(9):S135.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"3927_CR71","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/imm.13663","volume":"170","author":"S Kareem","year":"2023","unstructured":"Kareem S, Jacob A, Mathew J, Quigg RJ, Alexander JJ. Complement: Functions, location and implications. Immunology. 2023;170(2):180\u201392.","journal-title":"Immunology"},{"issue":"1","key":"3927_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/157015909787602805","volume":"7","author":"M Kolev","year":"2009","unstructured":"Kolev M, Ruseva M, Harris C, Morgan B, Donev R. Implication of Complement System and its Regulators in Alzheimers Disease. Curr Neuropharmacol. 2009;7(1):1\u20138.","journal-title":"Curr Neuropharmacol"},{"key":"3927_CR73","doi-asserted-by":"publisher","first-page":"102282","DOI":"10.1016\/j.pneurobio.2022.102282","volume":"214","author":"SE Parker","year":"2022","unstructured":"Parker SE, Bellingham MC, Woodruff TM. Complement drives circuit modulation in the adult brain. Prog Neurobiol. 2022;214:102282.","journal-title":"Prog Neurobiol"},{"issue":"2","key":"3927_CR74","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/biom12020337","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen Y, Chu JMT, Chang RCC, Wong GTC. The complement system in the central nervous system: from neurodevelopment to neurodegeneration. Biomolecules. 2022;12(2):337.","journal-title":"Biomolecules"},{"issue":"6","key":"3927_CR75","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.tins.2018.03.009","volume":"41","author":"LG Coulthard","year":"2018","unstructured":"Coulthard LG, Hawksworth OA, Woodruff TM, Complement. The Emerging Architect of the Developing Brain. Trends Neurosci. 2018;41(6):373\u201384.","journal-title":"Trends Neurosci"},{"key":"3927_CR76","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnins.2020.00023","volume":"14","author":"J Magdalon","year":"2020","unstructured":"Magdalon J, Mansur F, Teles ESAL, de Goes VA, Reiner O, Serti\u00e9 AL. Complement System in Brain Architecture and Neurodevelopmental Disorders. Front Neurosci. 2020;14:23.","journal-title":"Front Neurosci"},{"issue":"6","key":"3927_CR77","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131(6):1164\u201378.","journal-title":"Cell"},{"key":"3927_CR78","doi-asserted-by":"publisher","unstructured":"Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic Pruning by Microglia Is Necessary for Normal Brain Development. Sci (American Association Advancement Science). 2011;333(6048):1456\u20138. https:\/\/doi.org\/10.1126\/science.1202529","DOI":"10.1126\/science.1202529"},{"issue":"4","key":"3927_CR79","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"P Schafer Dorothy","year":"2012","unstructured":"Schafer Dorothy P, Lehrman Emily K, Kautzman Amanda G, Koyama R, Mardinly Alan R, Yamasaki R, et al. Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron. 2012;74(4):691\u2013705.","journal-title":"Neuron"},{"issue":"9","key":"3927_CR80","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785\u201397.","journal-title":"Nat Immunol"},{"issue":"9","key":"3927_CR81","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s43587-022-00281-1","volume":"2","author":"B Dejanovic","year":"2022","unstructured":"Dejanovic B, Wu T, Tsai MC, Graykowski D, Gandham VD, Rose CM, et al. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer\u2019s disease mouse models. Nat Aging. 2022;2(9):837\u201350.","journal-title":"Nat Aging"},{"issue":"4","key":"3927_CR82","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0197-4580(97)00042-0","volume":"18","author":"S Webster","year":"1997","unstructured":"Webster S, Lue L-F, Brachova L, Tenner A, McGeer P, Terai K, et al. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer\u2019s disease. Neurobiol Aging. 1997;18(4):415\u201321. https:\/\/doi.org\/10.1016\/s0197-4580(97)00042-0","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3927_CR83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s004019570001","volume":"91","author":"R Veerhuis","year":"1995","unstructured":"Veerhuis R, Janssen I, Hack C, Eikelenboom P. Early complement components in Alzheimer\u2019s disease brains. Acta Neuropathol. 1995;91(1):53\u201360.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3927_CR84","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-5-9","volume":"5","author":"DA Loeffler","year":"2008","unstructured":"Loeffler DA, Camp DM, Bennett DA. Plaque complement activation and cognitive loss in Alzheimer\u2019s disease. J Neuroinflamm. 2008;5(1):9.","journal-title":"J Neuroinflamm"},{"issue":"2","key":"3927_CR85","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0002-9440(10)64753-0","volume":"156","author":"SE Stoltzner","year":"2000","unstructured":"Stoltzner SE, Grenfell TJ, Mori C, Wisniewski KE, Wisniewski TM, Selkoe DJ, et al. Temporal accrual of complement proteins in amyloid plaques in Down\u2019s syndrome with Alzheimer\u2019s disease. Am J Pathol. 2000;156(2):489\u201399.","journal-title":"Am J Pathol"},{"issue":"1","key":"3927_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00011-025-02069-6","volume":"74","author":"E Vataja","year":"2025","unstructured":"Vataja E, Ratti G, Safa A, Pagano M, Ferrante L, Meri S, et al. Exploring the intersection of atherosclerosis and Alzheimer\u2019s disease: the role of inflammation and complement activation. Inflamm Res. 2025;74(1):1\u201313.","journal-title":"Inflamm Res"},{"issue":"1","key":"3927_CR87","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12883-023-03503-0","volume":"23","author":"X-C Zhu","year":"2023","unstructured":"Zhu X-C, Tang B-F, Zhu M-Z, Lu J, Lin H-X, Tang J-M, et al. Analysis of complement system and its related factors in Alzheimer\u2019s disease. BMC Neurol. 2023;23(1):446.","journal-title":"BMC Neurol"},{"issue":"11","key":"3927_CR88","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1097\/00007890-199612150-00032","volume":"62","author":"B Heckl-\u00d6streicher","year":"1996","unstructured":"Heckl-\u00d6streicher B, Wosnik A, Kirschfink M. Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor, and soluble complement receptor type 1: analysis in a pig-to-human in vitro model relevant to hyperacute xenograft rejection. Transplantation. 1996;62(11):1693\u20136.","journal-title":"Transplantation"},{"issue":"2","key":"3927_CR89","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0006-8993(99)01514-0","volume":"833","author":"K Yasojima","year":"1999","unstructured":"Yasojima K, McGeer EG, McGeer PL. Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease. Brain Res. 1999;833(2):297\u2013301.","journal-title":"Brain Res"},{"issue":"2","key":"3927_CR90","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","volume":"36","author":"H Lian","year":"2016","unstructured":"Lian H, Litvinchuk A, Chiang AC-A, Aithmitti N, Jankowsky JL, Zheng H. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer\u2019s Disease. J Neurosci. 2016;36(2):577\u201389.","journal-title":"J Neurosci"},{"issue":"1","key":"3927_CR91","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","volume":"85","author":"H Lian","year":"2015","unstructured":"Lian H, Yang L, Cole A, Sun L, Chiang AC-A, Fowler SW, et al. NF\u03baB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer\u2019s disease. Neuron. 2015;85(1):101\u201315.","journal-title":"Neuron"},{"issue":"7","key":"3927_CR92","doi-asserted-by":"publisher","first-page":"e70458","DOI":"10.1002\/alz.70458","volume":"21","author":"N Daskoulidou","year":"2025","unstructured":"Daskoulidou N, Shaw B, Zelek WM, Morgan BP. The Alzheimer\u2019s disease-associated complement receptor 1 variant confers risk by impacting glial phagocytosis. Alzheimer\u2019s Dement. 2025;21(7):e70458.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"10","key":"3927_CR93","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1038\/s41380-019-0536-8","volume":"26","author":"SH Krance","year":"2021","unstructured":"Krance SH, Wu C-Y, Zou Y, Mao H, Toufighi S, He X, et al. The complement cascade in Alzheimer\u2019s disease: a systematic review and meta-analysis. Mol Psychiatry. 2021;26(10):5532\u201341. https:\/\/doi.org\/10.1038\/s41380-019-0536-8","journal-title":"Mol Psychiatry"},{"key":"3927_CR94","doi-asserted-by":"crossref","unstructured":"Gao J, Li Z, Zhang X, Huang W, Tian Z, Xiao C et al. Advances in research on the complement system and cognitive impairment. Immunobiology. 2026:153157.","DOI":"10.1016\/j.imbio.2026.153157"},{"issue":"2","key":"3927_CR95","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/JAD-160420","volume":"54","author":"S Hakobyan","year":"2016","unstructured":"Hakobyan S, Harding K, Aiyaz M, Hye A, Dobson R, Baird A, et al. Complement Biomarkers as Predictors of Disease Progression in Alzheimer\u2019s Disease. J Alzheimers Dis. 2016;54(2):707\u201316.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"3927_CR96","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/13872877251322808","volume":"104","author":"R-J Xue","year":"2025","unstructured":"Xue R-J, Gao P-Y, Chen Y-M, Liu Y, Han B-L, Huang Y-M, et al. Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease pathology in cognitively intact adults: The CABLE study. J Alzheimer\u2019s Disease. 2025;104(4):1136\u201346.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"5","key":"3927_CR97","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/j.1471-4159.2008.05668.x","volume":"107","author":"JJ Alexander","year":"2008","unstructured":"Alexander JJ, Anderson AJ, Barnum SR, Stevens B, Tenner AJ. The complement cascade: Yin\u2013Yang in neuroinflammation \u2013 neuro-protection and -degeneration. J Neurochem. 2008;107(5):1169\u201387.","journal-title":"J Neurochem"},{"key":"3927_CR98","doi-asserted-by":"crossref","unstructured":"Batista AF, Khan KA, Papavergi MT, Lemere CA. The Importance of Complement-Mediated Immune Signaling in Alzheimer\u2019s Disease Pathogenesis. Int J Mol Sci. 2024;25(2).","DOI":"10.3390\/ijms25020817"},{"key":"3927_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-022-01404-w","volume":"10","author":"SM Carpanini","year":"2022","unstructured":"Carpanini SM, Torvell M, Bevan RJ, Byrne RAJ, Daskoulidou N, Saito T, et al. Terminal complement pathway activation drives synaptic loss in Alzheimer\u2019s disease models. Acta Neuropathol Commun. 2022;10:1\u201316.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"3927_CR100","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0002-9440(10)65340-0","volume":"154","author":"K Yasojima","year":"1999","unstructured":"Yasojima K, Schwab C, McGeer EG, McGeer PL. Up-Regulated Production and Activation of the Complement System in Alzheimer\u2019s Disease Brain. Am J Pathol. 1999;154(3):927\u201336.","journal-title":"Am J Pathol"},{"issue":"2","key":"3927_CR101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/01.wad.0000165506.60370.94","volume":"19","author":"H Zanjani","year":"2005","unstructured":"Zanjani H, Finch CE, Kemper C, Atkinson J, McKeel D, Morris JC, et al. Complement Activation in Very Early Alzheimer Disease. Alzheimer Dis Assoc Disord. 2005;19(2):55\u201366.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"3927_CR102","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2047-9158-2-21","volume":"2","author":"Y Shen","year":"2013","unstructured":"Shen Y, Yang L, Li R. What does complement do in Alzheimer\u2019s disease? Old molecules with new insights. Translational Neurodegeneration. 2013;2(1):21.","journal-title":"Translational Neurodegeneration"},{"issue":"3","key":"3927_CR103","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/13506129709014379","volume":"4","author":"MD Watson","year":"1997","unstructured":"Watson MD, Roher AE, Kim K, Spiegel K, Emmerlin MR. Complement interactions with amyloid \u03b21\u201342: a nidus for inflammation in AD brains. Amyloid. 1997;4(3):147\u201356.","journal-title":"Amyloid"},{"issue":"3","key":"3927_CR104","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1046\/j.1365-2249.1999.00835.x","volume":"115","author":"L Bergamaschini","year":"1999","unstructured":"Bergamaschini L, Canziani S, Bottasso B, Cugno M, Braidotti P, Agostoni A. Alzheimer\u2019s \u03b2-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner. Clin Experimental Immunol. 1999;115(3):526\u201333. https:\/\/doi.org\/10.1046\/j.1365-2249.1999.00835.x","journal-title":"Clin Experimental Immunol"},{"issue":"3","key":"3927_CR105","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1084\/jem.188.3.431","volume":"188","author":"BM Bradt","year":"1998","unstructured":"Bradt BM, Kolb WP, Cooper NR. Complement-dependent proinflammatory properties of the Alzheimer\u2019s disease \u03b2-peptide. J Exp Med. 1998;188(3):431\u20138.","journal-title":"J Exp Med"},{"issue":"3","key":"3927_CR106","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1006\/bbrc.1995.2852","volume":"217","author":"S Webster","year":"1995","unstructured":"Webster S, Glabe C, Rogers J. Multivalent binding of complement protein C1q to the amyloid \u03b2-peptide (A\u03b2) promotes the nucleation phase of A\u03b2 aggregation. Biochem Biophys Res Commun. 1995;217(3):869\u201375.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3927_CR107","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.expneurol.2003.09.023","volume":"185","author":"R Fan","year":"2004","unstructured":"Fan R, Tenner AJ. Complement C1q expression induced by A\u03b2 in rat hippocampal organotypic slice cultures. Exp Neurol. 2004;185(2):241\u201353.","journal-title":"Exp Neurol"},{"issue":"29","key":"3927_CR108","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1523\/JNEUROSCI.0901-04.2004","volume":"24","author":"MI Fonseca","year":"2004","unstructured":"Fonseca MI, Zhou J, Botto M, Tenner AJ. Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer\u2019s disease. J Neurosci. 2004;24(29):6457\u201365.","journal-title":"J Neurosci"},{"key":"3927_CR109","doi-asserted-by":"crossref","unstructured":"Wang J, Wu J, Ma X, Wu Y, Xiao Z, Zhou X et al. A Double-Edged Sword: Exploring the Neuroprotective\/Damaging Mechanisms of Complement Activation in Alzheimer\u2019s Disease. Aging Health Res. 2025:100267.","DOI":"10.1016\/j.ahr.2025.100267"},{"issue":"3","key":"3927_CR110","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/imm.13929","volume":"175","author":"R Cao","year":"2025","unstructured":"Cao R, Zhu LW, Chen B, Wu H, Cheng Y, Guo S. The Contribution of Complement System in Multiple Sclerosis: Mechanisms and Therapeutic Potentials. Immunology. 2025;175(3):263\u201379.","journal-title":"Immunology"},{"issue":"1","key":"3927_CR111","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1074\/jbc.M112.400168","volume":"288","author":"ME Benoit","year":"2013","unstructured":"Benoit ME, Hernandez MX, Dinh ML, Benavente F, Vasquez O, Tenner AJ. C1q-induced LRP1B and GPR6 Proteins Expressed Early in Alzheimer Disease Mouse Models, Are Essential for the C1q-mediated Protection against Amyloid-\u03b2 Neurotoxicity. J Biol Chem. 2013;288(1):654\u201365.","journal-title":"J Biol Chem"},{"key":"3927_CR112","doi-asserted-by":"publisher","first-page":"110685","DOI":"10.1016\/j.brainresbull.2023.110685","volume":"200","author":"Y Yao","year":"2023","unstructured":"Yao Y, Chang Y, Li S, Zhu J, Wu Y, Jiang X, et al. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice. Brain Res Bull. 2023;200:110685.","journal-title":"Brain Res Bull"},{"key":"3927_CR113","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejphar.2019.02.020","volume":"850","author":"J Hu","year":"2019","unstructured":"Hu J, Yang Y, Wang M, Yao Y, Chang Y, He Q, et al. Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3\u03b2 signaling pathways. Eur J Pharmacol. 2019;850:135\u201340.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"3927_CR114","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3390\/genes12121990","volume":"12","author":"M Torvell","year":"2021","unstructured":"Torvell M, Carpanini SM, Daskoulidou N, Byrne RAJ, Sims R, Morgan BP. Genetic Insights into the Impact of Complement in Alzheimer\u2019s Disease. Genes. 2021;12(12):1990.","journal-title":"Genes"},{"issue":"1","key":"3927_CR115","doi-asserted-by":"publisher","first-page":"175909141668787","DOI":"10.1177\/1759091416687871","volume":"9","author":"MX Hernandez","year":"2017","unstructured":"Hernandez MX, Namiranian P, Nguyen E, Fonseca MI, Tenner AJ. C5a increases the injury to primary neurons elicited by fibrillar amyloid beta. ASN neuro. 2017;9(1):1759091416687871.","journal-title":"ASN neuro"},{"key":"3927_CR116","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1051\/medsci\/201834f120","volume":"34","author":"X-q An","year":"2018","unstructured":"An X-q, Xi W, Gu C-y, Huang X. Complement protein C5a enhances the \u03b2-amyloid-induced neuro-inflammatory response in microglia in Alzheimer\u2019s disease. m\u00e9decine\/sciences. 2018;34:116\u201320.","journal-title":"m\u00e9decine\/sciences"},{"issue":"n\/a","key":"3927_CR117","doi-asserted-by":"publisher","first-page":"2350815","DOI":"10.1002\/eji.202350815","volume":"n\/a","author":"M Gedam","year":"2024","unstructured":"Gedam M, Zheng H. Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer\u2019s disease. Eur J Immunol. 2024;n\/a(n\/a):2350815.","journal-title":"Eur J Immunol"},{"issue":"null","key":"3927_CR118","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2147\/ITT.S305420","volume":"10","author":"A Gomez-Arboledas","year":"2021","unstructured":"Gomez-Arboledas A, Acharya MM, Tenner AJ. The Role of Complement in Synaptic Pruning and Neurodegeneration. ImmunoTargets Therapy. 2021;10(null):373\u201386.","journal-title":"ImmunoTargets Therapy"},{"issue":"1","key":"3927_CR119","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12974-022-02539-2","volume":"19","author":"K Carvalho","year":"2022","unstructured":"Carvalho K, Schartz ND, Balderrama-Gutierrez G, Liang HY, Chu S-H, Selvan P, et al. Modulation of C5a\u2013C5aR1 signaling alters the dynamics of AD progression. J Neuroinflamm. 2022;19(1):178.","journal-title":"J Neuroinflamm"},{"key":"3927_CR120","doi-asserted-by":"crossref","unstructured":"Bhatia K, Ahmad S, Kindelin A, Ducruet AF. Complement C3a receptor\u2013mediated vascular dysfunction: a complex interplay between aging and neurodegeneration. J Clin Investig. 2021;131(1).","DOI":"10.1172\/JCI144348"},{"issue":"3","key":"3927_CR121","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/alz.13682","volume":"20","author":"A Gomez-Arboledas","year":"2024","unstructured":"Gomez-Arboledas A, Fonseca MI, Kramar E, Chu SH, Schartz ND, Selvan P, et al. C5aR1 signaling promotes region\u2010and age\u2010dependent synaptic pruning in models of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2024;20(3):2173\u201390.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"2","key":"3927_CR122","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71185","volume":"22","author":"Q Ye","year":"2026","unstructured":"Ye Q, Gao W, Feng J, Li X, Li J, Yang F, et al. Spatial heterogeneity in microglia-complement crosstalk: implications for synaptic pruning in Alzheimer\u2019s disease. Alzheimers Dement. 2026;22(2):e71185.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"3927_CR123","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/mp.2017.246","volume":"23","author":"KE Hopperton","year":"2018","unstructured":"Hopperton KE, Mohammad D, Tr\u00e9panier MO, Giuliano V, Bazinet RP. Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: a systematic review. Mol Psychiatry. 2018;23(2):177\u201398.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"3927_CR124","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13195-015-0126-1","volume":"7","author":"D Gomez-Nicola","year":"2015","unstructured":"Gomez-Nicola D, Boche D. Post-mortem analysis of neuroinflammatory changes in human Alzheimer\u2019s disease. Alzheimers Res Ther. 2015;7(1):42.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"3927_CR125","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/2051-5960-2-53","volume":"2","author":"G Ingram","year":"2014","unstructured":"Ingram G, Loveless S, Howell OW, Hakobyan S, Dancey B, Harris CL, et al. Complement activation in multiple sclerosis plaques: an immunohistochemical analysis. Acta Neuropathol Commun. 2014;2(1):53.","journal-title":"Acta Neuropathol Commun"},{"issue":"15","key":"3927_CR126","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/WNR.0000000000000661","volume":"27","author":"D Wang","year":"2016","unstructured":"Wang D, Di X, Fu L, Li Y, Han X, Wu H, et al. Analysis of serum \u03b2-amyloid peptides, \u03b12-macroglobulin, complement factor H, and clusterin levels in APP\/PS1 transgenic mice during progression of Alzheimer\u2019s disease. NeuroReport. 2016;27(15):1114\u20139.","journal-title":"NeuroReport"},{"issue":"4","key":"3927_CR127","doi-asserted-by":"publisher","first-page":"152944","DOI":"10.1016\/j.imbio.2025.152944","volume":"230","author":"A Veteleanu","year":"2025","unstructured":"Veteleanu A, Wijesuriya V, Sogorb-Esteve A, Zetterberg H, Zelek W, Morgan P. Cerebrospinal fluid complement system biomarkers in Alzheimer\u2019s disease. Immunobiology. 2025;230(4):152944.","journal-title":"Immunobiology"},{"issue":"6","key":"3927_CR128","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1515\/mr-2023-0071","volume":"4","author":"C An","year":"2024","unstructured":"An C, Cai H, Ren Z, Fu X, Quan S, Jia L. Biofluid biomarkers for Alzheimer\u2019s disease: past, present, and future. Med Rev. 2024;4(6):467\u201391.","journal-title":"Med Rev"},{"key":"3927_CR129","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2019.07.050","volume":"416","author":"X Shi","year":"2019","unstructured":"Shi X, Ohta Y, Liu X, Shang J, Morihara R, Nakano Y, et al. Chronic cerebral hypoperfusion activates the coagulation and complement cascades in Alzheimer\u2019s disease mice. Neuroscience. 2019;416:126\u201336.","journal-title":"Neuroscience"},{"issue":"3","key":"3927_CR130","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.25172","volume":"83","author":"EJ Goetzl","year":"2018","unstructured":"Goetzl EJ, Schwartz JB, Abner EL, Jicha GA, Kapogiannis D. High complement levels in astrocyte-derived exosomes of Alzheimer disease. Ann Neurol. 2018;83(3):544\u201352.","journal-title":"Ann Neurol"},{"key":"3927_CR131","doi-asserted-by":"crossref","unstructured":"Nguyen VD, Bright M, Zhou Y, Morgan BP, Zelek WM. Complement biosynthesis in human brain: Insights from single-nucleus transcriptomics of hippocampus. bioRxiv. 2025:2025.05.06.652374.","DOI":"10.1101\/2025.05.06.652374"},{"issue":"1","key":"3927_CR132","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s44477-025-00002-z","volume":"1","author":"DR Avey","year":"2025","unstructured":"Avey DR, Ng B, Vialle RA, Kearns NA, de Paiva Lopes K, Iatrou A, et al. Uncovering plaque-glia niches in human Alzheimer\u2019s disease brains using spatial transcriptomics. Mol Neurodegeneration Adv. 2025;1(1):2.","journal-title":"Mol Neurodegeneration Adv"},{"issue":"1","key":"3927_CR133","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-025-02857-8","volume":"149","author":"S Fixemer","year":"2025","unstructured":"Fixemer S, Miranda de la Maza M, Hammer GP, Jeannelle F, Schreiner S, G\u00e9rardy J-J, et al. Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer\u2019s disease hippocampus. Acta Neuropathol. 2025;149(1):19.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3927_CR134","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/genbio.2023.0019","volume":"2","author":"SH Kwon","year":"2023","unstructured":"Kwon SH, Parthiban S, Tippani M, Divecha HR, Eagles NJ, Lobana JS, et al. Influence of Alzheimer\u2019s disease related neuropathology on local microenvironment gene expression in the human inferior temporal cortex. GEN Biotechnol. 2023;2(5):399\u2013417.","journal-title":"GEN Biotechnol"},{"key":"3927_CR135","doi-asserted-by":"crossref","unstructured":"Bayaraa O, Aksu M, DeBose-Scarlett E, Hocke E, Jain V, Wang S-HJ et al. Multi-region spatial transcriptomics reveals region specific differences in response to amyloid beta (A\u03b2) plaque induced changes in Alzheimer\u2019s Disease (AD). Hum Genomics. 2025.","DOI":"10.1101\/2025.07.31.667719"},{"key":"3927_CR136","doi-asserted-by":"crossref","unstructured":"Garg A, Vo S, De Souza ID, Castro Brant A, Brase L, Aladyeva E, et al. Exploring cellular heterogeneity: single-cell and spatial transcriptomics of Alzheimer\u2019s disease brains and iPSC-derived microglia. Alzheimer\u2019s Research & Therapy; 2025.","DOI":"10.21203\/rs.3.rs-5045715\/v1"},{"key":"3927_CR137","doi-asserted-by":"publisher","first-page":"1055050","DOI":"10.3389\/fimmu.2022.1055050","volume":"13","author":"M Burgelman","year":"2022","unstructured":"Burgelman M, Dujardin P, Vandendriessche C, Vandenbroucke RE. Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders. Front Immunol. 2022;13:1055050.","journal-title":"Front Immunol"},{"key":"3927_CR138","doi-asserted-by":"publisher","first-page":"1007102","DOI":"10.3389\/fimmu.2022.1007102","volume":"13","author":"RJ Brandwijk","year":"2022","unstructured":"Brandwijk RJ, Michels MA, van Rossum M, de Nooijer AH, Nilsson PH, de Bruin WC, et al. Pitfalls in complement analysis: A systematic literature review of assessing complement activation. Front Immunol. 2022;13:1007102.","journal-title":"Front Immunol"},{"issue":"8100","key":"3927_CR139","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41586-025-10018-w","volume":"650","author":"H Zetterberg","year":"2026","unstructured":"Zetterberg H, Bendlin BB. Biofluid biomarkers in Alzheimer\u2019s disease and other neurodegenerative dementias. Nature. 2026;650(8100):49\u201359. https:\/\/doi.org\/10.1038\/s41586-025-10018-w","journal-title":"Nature"},{"key":"3927_CR140","doi-asserted-by":"publisher","first-page":"102599","DOI":"10.1016\/j.arr.2024.102599","volume":"104","author":"K Hari Krishnan","year":"2025","unstructured":"Hari Krishnan K, Vasanth J, Karthik K, Tianhao W, Kang B, Chithra C, et al. An overview of the genes and biomarkers in Alzheimer\u2019s disease. Ageing Res Rev. 2025;104:102599.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"3927_CR141","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41380-024-02709-z","volume":"30","author":"TR Hunter","year":"2025","unstructured":"Hunter TR, Santos LE, Tovar-Moll F, De Felice FG. Alzheimer\u2019s disease biomarkers and their current use in clinical research and practice. Mol Psychiatry. 2025;30(1):272\u201384.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"3927_CR142","doi-asserted-by":"publisher","first-page":"658","DOI":"10.14336\/AD.2024.0286","volume":"16","author":"JA Pradeepkiran","year":"2024","unstructured":"Pradeepkiran JA, Baig J, Islam MA, Kshirsagar S, Reddy PH. Amyloid-\u03b2 and phosphorylated tau are the key biomarkers and predictors of Alzheimer\u2019s disease. Aging disease. 2024;16(2):658.","journal-title":"Aging disease"},{"issue":"5","key":"3927_CR143","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-025-03565-2","volume":"31","author":"HS-H Oh","year":"2025","unstructured":"Oh HS-H, Urey DY, Karlsson L, Zhu Z, Shen Y, Farinas A, et al. A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer\u2019s disease. Nat Med. 2025;31(5):1592\u2013603.","journal-title":"Nat Med"},{"issue":"7","key":"3927_CR144","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/brain\/awab092","volume":"144","author":"PA Boyle","year":"2021","unstructured":"Boyle PA, Wang T, Yu L, Wilson RS, Dawe R, Arfanakis K, et al. To what degree is late life cognitive decline driven by age-related neuropathologies? Brain. 2021;144(7):2166\u201375.","journal-title":"Brain"},{"key":"3927_CR145","doi-asserted-by":"publisher","first-page":"100063","DOI":"10.1016\/j.bionps.2023.100063","volume":"8","author":"JE Georgakas","year":"2023","unstructured":"Georgakas JE, Howe MD, Thompson LI, Riera NM, Riddle MC. Biomarkers of Alzheimer\u2019s disease: Past, present and future clinical use. Biomarkers Neuropsychiatry. 2023;8:100063.","journal-title":"Biomarkers Neuropsychiatry"},{"issue":"1","key":"3927_CR146","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13195-022-01117-1","volume":"14","author":"AL Brand","year":"2022","unstructured":"Brand AL, Lawler PE, Bollinger JG, Li Y, Schindler SE, Li M, et al. The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer\u2019s disease: a literature review. Alzheimers Res Ther. 2022;14(1):195. https:\/\/doi.org\/10.1186\/s13195-022-01117-1","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"3927_CR147","doi-asserted-by":"publisher","first-page":"7998","DOI":"10.1038\/s41467-024-52396-1","volume":"15","author":"X Huang","year":"2024","unstructured":"Huang X, Fowler C, Li Y, Li Q-X, Sun J, Pan Y, et al. Clearance and transport of amyloid \u03b2 by peripheral monocytes correlate with Alzheimer\u2019s disease progression. Nat Commun. 2024;15(1):7998.","journal-title":"Nat Commun"},{"issue":"7691","key":"3927_CR148","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dor\u00e9 V, et al. High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature. 2018;554(7691):249\u201354.","journal-title":"Nature"},{"key":"3927_CR149","doi-asserted-by":"publisher","first-page":"1345417","DOI":"10.3389\/fnagi.2024.1345417","volume":"16","author":"M Mehdipour Ghazi","year":"2024","unstructured":"Mehdipour Ghazi M, Selnes P, Tim\u00f3n-Reina S, Tecel\u00e3o S, Ingala S, Bj\u00f8rnerud A, et al. Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer\u2019s disease cohorts. Front Aging Neurosci. 2024;16:1345417.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3927_CR150","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13195-017-0324-0","volume":"9","author":"MJ Wang","year":"2017","unstructured":"Wang MJ, Yi S, Han J-y, Park SY, Jang J-W, Chun IK, et al. Oligomeric forms of amyloid-\u03b2 protein in plasma as a potential blood-based biomarker for Alzheimer\u2019s disease. Alzheimers Res Ther. 2017;9(1):98.","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"3927_CR151","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S1474-4422(25)00227-3","volume":"24","author":"J Therriault","year":"2025","unstructured":"Therriault J, Brum WS, Trudel L, Macedo AC, Bitencourt FV, Martins-Pfeifer CC, et al. Blood phosphorylated tau for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 2025;24(9):740\u201352.","journal-title":"Lancet Neurol"},{"issue":"8","key":"3927_CR152","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.122.265200","volume":"64","author":"AC Macedo","year":"2023","unstructured":"Macedo AC, Tissot C, Therriault J, Servaes S, Wang Y-T, Fernandez-Arias J, et al. The use of tau PET to stage Alzheimer disease according to the Braak staging framework. J Nucl Med. 2023;64(8):1171\u20138.","journal-title":"J Nucl Med"},{"issue":"3","key":"3927_CR153","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/brain\/awac407","volume":"146","author":"F Gonzalez-Ortiz","year":"2023","unstructured":"Gonzalez-Ortiz F, Turton M, Kac PR, Smirnov D, Premi E, Ghidoni R, et al. Brain-derived tau: a novel blood-based biomarker for Alzheimer\u2019s disease-type neurodegeneration. Brain. 2023;146(3):1152\u201365.","journal-title":"Brain"},{"issue":"Suppl 1","key":"3927_CR154","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","volume":"6","author":"K Blennow","year":"2017","unstructured":"Blennow K. A review of fluid biomarkers for Alzheimer\u2019s disease: moving from CSF to blood. Neurol Ther. 2017;6(Suppl 1):15\u201324.","journal-title":"Neurol Ther"},{"issue":"1","key":"3927_CR155","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000513008","volume":"84","author":"Y-l Xiong","year":"2021","unstructured":"Xiong Y-l, Meng T, Luo J, Zhang H. The potential of neurofilament light as a biomarker in Alzheimer\u2019s disease. Eur Neurol. 2021;84(1):6\u201315. https:\/\/doi.org\/10.1159\/000513008","journal-title":"Eur Neurol"},{"issue":"1","key":"3927_CR156","volume":"2024","author":"DN Abukuri","year":"2024","unstructured":"Abukuri DN. Novel biomarkers for Alzheimer\u2019s disease: plasma neurofilament light and cerebrospinal fluid. Int J Alzheimers Dis. 2024;2024(1):6668159.","journal-title":"Int J Alzheimers Dis"},{"issue":"11","key":"3927_CR157","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/brain\/awab223","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE, et al. Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease. Brain. 2021;144(11):3505\u201316.","journal-title":"Brain"},{"issue":"1","key":"3927_CR158","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13024-023-00657-w","volume":"18","author":"I Pes\u00e4maa","year":"2023","unstructured":"Pes\u00e4maa I, M\u00fcller SA, Robinson S, Darcher A, Paquet D, Zetterberg H, et al. A microglial activity state biomarker panel differentiates FTD-granulin and Alzheimer\u2019s disease patients from controls. Mol Neurodegener. 2023;18(1):70.","journal-title":"Mol Neurodegener"},{"issue":"24","key":"3927_CR159","doi-asserted-by":"publisher","first-page":"e2944","DOI":"10.1212\/WNL.0000000000012109","volume":"96","author":"B Bellaver","year":"2021","unstructured":"Bellaver B, Ferrari-Souza JP, Uglione da Ros L, Carter SF, Rodriguez-Vieitez E, Nordberg A, et al. Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis. Neurology. 2021;96(24):e2944\u201355.","journal-title":"Neurology"},{"issue":"2","key":"3927_CR160","doi-asserted-by":"publisher","first-page":"e14458","DOI":"10.1002\/alz.14458","volume":"21","author":"M Khalafi","year":"2025","unstructured":"Khalafi M, Dartora WJ, McIntire LBJ, Butler TA, Wartchow KM, Hojjati SH, et al. Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer\u2019s disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis. Alzheimer\u2019s Dement. 2025;21(2):e14458.","journal-title":"Alzheimer\u2019s Dement"},{"key":"3927_CR161","doi-asserted-by":"crossref","unstructured":"Antonioni A, Raho EM, Manzoli L, Koch G, Flacco ME, Di Lorenzo F. Blood phosphorylated Tau181 reliably differentiates amyloid-positive from amyloid\u2010negative subjects in the Alzheimer\u2019s disease continuum: A systematic review and meta\u2010analysis. Alzheimer\u2019sDementia:, Diagnosis. Assessment & Disease Monitoring. 2025;17(1):e70068.","DOI":"10.1002\/dad2.70068"},{"key":"3927_CR162","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fnagi.2019.00254","volume":"11","author":"M Jin","year":"2019","unstructured":"Jin M, Cao L, Dai Y-p. Role of neurofilament light chain as a potential biomarker for Alzheimer\u2019s disease: a correlative meta-analysis. Front Aging Neurosci. 2019;11:254. https:\/\/doi.org\/10.3389\/fnagi.2019.00254","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"3927_CR163","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00415-023-12066-6","volume":"271","author":"A Vrillon","year":"2024","unstructured":"Vrillon A, Ashton NJ, Karikari TK, G\u00f6tze K, Cognat E, Dumurgier J, et al. Comparison of CSF and plasma NfL and pNfH for Alzheimer\u2019s disease diagnosis: a memory clinic study. J Neurol. 2024;271(3):1297\u2013310.","journal-title":"J Neurol"},{"issue":"12","key":"3927_CR164","doi-asserted-by":"publisher","first-page":"15576","DOI":"10.1007\/s12035-025-05219-3","volume":"62","author":"EM Bandara","year":"2025","unstructured":"Bandara EM, Asih PR, Pedrini S, Hone E, Fernando WMADB, Martins RN. The role of glial fibrillary acidic protein in the neuropathology of Alzheimer\u2019s disease and its potential as a blood biomarker for early diagnosis and progression. Mol Neurobiol. 2025;62(12):15576\u2013608.","journal-title":"Mol Neurobiol"},{"issue":"9","key":"3927_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091309","volume":"12","author":"KY Kim","year":"2023","unstructured":"Kim KY, Shin KY, Chang K-A. GFAP as a potential biomarker for Alzheimer\u2019s disease: a systematic review and meta-analysis. Cells. 2023;12(9):1309.","journal-title":"Cells"},{"issue":"4","key":"3927_CR166","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/clinchem\/hvad018","volume":"69","author":"X-N Shen","year":"2023","unstructured":"Shen X-N, Huang S-Y, Cui M, Zhao Q-H, Guo Y, Huang Y-Y, et al. Plasma glial fibrillary acidic protein in the Alzheimer disease continuum: relationship to other biomarkers, differential diagnosis, and prediction of clinical progression. Clin Chem. 2023;69(4):411\u201321.","journal-title":"Clin Chem"},{"key":"3927_CR167","doi-asserted-by":"crossref","unstructured":"Daskoulidou N, Carpanini SM, Zelek WM, Morgan BP. Involvement of Complement in Alzheimer\u2019s Disease: From Genetics Through Pathology to Therapeutic Strategies. 2024.","DOI":"10.1007\/7854_2024_524"},{"issue":"9","key":"3927_CR168","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1474-4422(25)00274-1","volume":"24","author":"A Keshavan","year":"2025","unstructured":"Keshavan A, Algeciras-Schimnich A. Plasma phosphorylated tau for Alzheimer\u2019s disease diagnosis. Lancet Neurol. 2025;24(9):715\u20137. https:\/\/doi.org\/10.1016\/S1474-4422(25)00274-1","journal-title":"Lancet Neurol"},{"issue":"1","key":"3927_CR169","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1038\/s41467-026-71732-1","volume":"17","author":"LE Collij","year":"2026","unstructured":"Collij LE, Salvad\u00f3 G, Horie K, Barth\u00e9lemy NR, Betthauser TJ, Strandberg O, et al. Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer\u2019s disease continuum. Nat Commun. 2026;17(1):3400.","journal-title":"Nat Commun"},{"issue":"12","key":"3927_CR170","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1093\/brain\/awaa342","volume":"143","author":"AL Benedet","year":"2020","unstructured":"Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M, et al. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer\u2019s disease. Brain. 2020;143(12):3793\u2013804.","journal-title":"Brain"},{"issue":"1","key":"3927_CR171","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","volume":"11","author":"P Chatterjee","year":"2021","unstructured":"Chatterjee P, Pedrini S, Stoops E, Goozee K, Villemagne VL, Asih PR, et al. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease. Translational psychiatry. 2021;11(1):27.","journal-title":"Translational psychiatry"},{"issue":"2","key":"3927_CR172","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41380-025-03166-y","volume":"31","author":"X Huang","year":"2026","unstructured":"Huang X, Han X, Chang H, Yu T, Dong Y, Mao M, et al. Associations between trajectories of plasma biomarkers for Alzheimer\u2019s disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank. Mol Psychiatry. 2026;31(2):749\u201360.","journal-title":"Mol Psychiatry"},{"key":"3927_CR173","first-page":"61","volume":"11","author":"CN Winston","year":"2019","unstructured":"Winston CN, Goetzl EJ, Schwartz JB, Elahi FM, Rissman RA. Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer\u2019s disease dementia. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2019;11:61\u20136.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"issue":"1","key":"3927_CR174","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-230799","volume":"98","author":"Z Li","year":"2024","unstructured":"Li Z, Fan Z, Zhang Q. The associations of Phosphorylated Tau 181 and tau 231 levels in plasma and cerebrospinal fluid with cognitive function in Alzheimer\u2019s Disease: a systematic review and Meta-analysis. J Alzheimer\u2019s Disease. 2024;98(1):13\u201332.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"3927_CR175","doi-asserted-by":"publisher","first-page":"254248232513798","DOI":"10.1177\/25424823251379878","volume":"9","author":"K Thomas","year":"2025","unstructured":"Thomas K, Spin P, Sir N, Hou K, Ashton NJ, Zetterberg H, et al. Neurofilament light (NfL) chain levels predict clinical decline in Alzheimer\u2019s disease: A systematic review and meta-analysis. J Alzheimer\u2019s Disease Rep. 2025;9:25424823251379878.","journal-title":"J Alzheimer\u2019s Disease Rep"},{"key":"3927_CR176","doi-asserted-by":"crossref","unstructured":"Luke W, Bonham RSD, corresponding, author# JS, Yokoyama. The relationship between complement factor C3, APOE \u03b54, amyloid and tau in Alzheimer\u2019s disease. Acta Neuropathol Commun. 2016;4(65).","DOI":"10.1186\/s40478-016-0339-y"},{"issue":"4","key":"3927_CR177","doi-asserted-by":"publisher","first-page":"802","DOI":"10.14283\/jpad.2024.122","volume":"11","author":"RA Sperling","year":"2024","unstructured":"Sperling RA, Donohue MC, Rissman RA, Johnson KA, Rentz DM, Grill JD, et al. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies. J Prev Alzheimer\u2019s Disease. 2024;11(4):802\u201313.","journal-title":"J Prev Alzheimer\u2019s Disease"},{"issue":"1","key":"3927_CR178","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1038\/s41467-026-71269-3","volume":"17","author":"H-S Yang","year":"2026","unstructured":"Yang H-S, Anzai JAU, Yau W-YW, Healy BC, Rom\u00e1n Viera AM, Maa C, et al. Plasma phosphorylated tau 217 and longitudinal trajectories of A\u03b2, tau, and cognition in cognitively unimpaired older adults. Nat Commun. 2026;17(1):3188.","journal-title":"Nat Commun"},{"issue":"8","key":"3927_CR179","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/cells12081184","volume":"12","author":"A Zabala-Findlay","year":"2023","unstructured":"Zabala-Findlay A, Penny LK, Lofthouse RA, Porter AJ, Palliyil S, Harrington CR, et al. Utility of blood-based tau biomarkers for mild cognitive impairment and Alzheimer\u2019s disease: systematic review and meta-analysis. Cells. 2023;12(8):1184.","journal-title":"Cells"},{"issue":"1","key":"3927_CR180","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/brain\/awad267","volume":"147","author":"Y Jung","year":"2024","unstructured":"Jung Y, Damoiseaux JS. The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer\u2019s disease. Brain. 2024;147(1):12\u201325.","journal-title":"Brain"},{"key":"3927_CR181","doi-asserted-by":"crossref","unstructured":"Wu J, Risk BB, James TA, Seyfried NT, Loring DW, Goldstein FC, et al. Non-linear associations of amyloid-\u03b2 with resting-state functional networks and their cognitive relevance in a large community-based cohort of cognitively normal older adults. Alzheimer\u2019s Research & Therapy; 2026.","DOI":"10.1186\/s13195-026-01986-w"},{"key":"3927_CR182","doi-asserted-by":"crossref","unstructured":"Noto NM, Speth RC, Robison LS. Cerebral amyloid angiopathy: a narrative review. Front Aging Neurosci. 2025;Volume 17\u20132025.","DOI":"10.3389\/fnagi.2025.1632252"},{"issue":"Suppl 1","key":"3927_CR183","doi-asserted-by":"publisher","first-page":"s13","DOI":"10.2967\/jnumed.121.263195","volume":"63","author":"M Chapleau","year":"2022","unstructured":"Chapleau M, Iaccarino L, Soleimani-Meigooni D, Rabinovici GD. The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review. J Nucl Med. 2022;63(Suppl 1):s13\u20139.","journal-title":"J Nucl Med"},{"issue":"2","key":"3927_CR184","doi-asserted-by":"publisher","first-page":"e14582","DOI":"10.1002\/alz.14582","volume":"21","author":"LE Wisse","year":"2025","unstructured":"Wisse LE, Wuestefeld A, Murray ME, Jagust W, La Joie R. Role of tau versus TDP-43 pathology on medial temporal lobe atrophy in aging and Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2025;21(2):e14582.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"6","key":"3927_CR185","doi-asserted-by":"publisher","first-page":"e70381","DOI":"10.1002\/alz.70381","volume":"21","author":"S Raghavan","year":"2025","unstructured":"Raghavan S, Graff-Radford J, Hofrenning E, Fought AJ, Reid RI, Kamykowski MG, et al. Plasma NfL and GFAP for predicting VCI and related brain changes in community and clinical cohorts. Alzheimer\u2019s Dement. 2025;21(6):e70381.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"3927_CR186","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12916-024-03418-8","volume":"22","author":"X Wang","year":"2024","unstructured":"Wang X, Shi Z, Qiu Y, Sun D, Zhou H. Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank. BMC Med. 2024;22(1):192.","journal-title":"BMC Med"},{"key":"3927_CR187","doi-asserted-by":"crossref","unstructured":"Kanuri SH, Sirrkay PJ. Deciphering the Structural Biology of GFAP: Connotations of Its Potency in Presaging the Diagnosis for Traumatic Brain Injury and AD. Neurol Int. 2025;17(9).","DOI":"10.3390\/neurolint17090134"},{"issue":"1","key":"3927_CR188","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JAD-200110","volume":"76","author":"M Chen","year":"2020","unstructured":"Chen M, Xia W. Proteomic profiling of plasma and brain tissue from Alzheimer\u2019s disease patients reveals candidate network of plasma biomarkers. J Alzheimer\u2019s Disease. 2020;76(1):349\u201368.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"3927_CR189","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s40478-025-02064-2","volume":"13","author":"D Bali","year":"2025","unstructured":"Bali D, Salvad\u00f3 G, Beach TG, Serrano GE, Atri A, Reiman EM, et al. Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort. Acta Neuropathol Commun. 2025;13(1):144.","journal-title":"Acta Neuropathol Commun"},{"key":"3927_CR190","doi-asserted-by":"publisher","first-page":"105046","DOI":"10.1016\/j.ebiom.2024.105046","volume":"102","author":"J Therriault","year":"2024","unstructured":"Therriault J, Ashton NJ, Pola I, Triana-Baltzer G, Brum WS, Di Molfetta G, et al. Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer\u2019s pathology. eBioMedicine. 2024;102:105046.","journal-title":"eBioMedicine"},{"issue":"1","key":"3927_CR191","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-024-01391-1","volume":"16","author":"D Bali","year":"2024","unstructured":"Bali D, Hansson O, Janelidze S. Effects of certain pre-analytical factors on the performance of plasma phospho-tau217. Alzheimers Res Ther. 2024;16(1):31.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"3927_CR192","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13195-022-00986-w","volume":"14","author":"AJ Weigand","year":"2022","unstructured":"Weigand AJ, Maass A, Eglit GL, Bondi MW. What\u2019s the cut-point? a systematic investigation of tau PET thresholding methods. Alzheimers Res Ther. 2022;14(1):49.","journal-title":"Alzheimers Res Ther"},{"key":"3927_CR193","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fnagi.2018.00414","volume":"10","author":"Z Cheng","year":"2018","unstructured":"Cheng Z, Yin J, Yuan H, Jin C, Zhang F, Wang Z, et al. Blood-derived plasma protein biomarkers for Alzheimer\u2019s disease in Han Chinese. Front Aging Neurosci. 2018;10:414.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3927_CR194","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13195-019-0532-x","volume":"11","author":"A de Wilde","year":"2019","unstructured":"de Wilde A, Reimand J, Teunissen CE, Zwan M, Windhorst AD, Boellaard R, et al. Discordant amyloid-\u03b2 PET and CSF biomarkers and its clinical consequences. Alzheimers Res Ther. 2019;11(1):78.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"3927_CR195","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/alz.13450","volume":"20","author":"W Pelkmans","year":"2024","unstructured":"Pelkmans W, Shekari M, Brugulat-Serrat A, S\u00e1nchez-Benavides G, Minguill\u00f3n C, Fauria K, et al. Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer\u2019s disease progression. Alzheimers Dement. 2024;20(1):483\u201393.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"3927_CR196","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.3390\/molecules29122812","volume":"29","author":"J Yang","year":"2024","unstructured":"Yang J, Zhi W, Wang L. Role of tau protein in neurodegenerative diseases and development of its targeted drugs: a literature review. Molecules. 2024;29(12):2812.","journal-title":"Molecules"},{"issue":"4","key":"3927_CR197","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","volume":"20","author":"J Therriault","year":"2024","unstructured":"Therriault J, Schindler SE, Salvad\u00f3 G, Pascoal TA, Benedet AL, Ashton NJ, et al. Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat Reviews Neurol. 2024;20(4):232\u201344.","journal-title":"Nat Reviews Neurol"},{"issue":"5","key":"3927_CR198","doi-asserted-by":"publisher","first-page":"EMMM202217123","DOI":"10.15252\/emmm.202217123","volume":"15","author":"G Salvad\u00f3","year":"2023","unstructured":"Salvad\u00f3 G, Ossenkoppele R, Ashton NJ, Beach TG, Serrano GE, Reiman EM, et al. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads. EMBO Mol Med. 2023;15(5):EMMM202217123.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"3927_CR199","doi-asserted-by":"publisher","first-page":"e70163","DOI":"10.1111\/eci.70163","volume":"56","author":"E Harput","year":"2026","unstructured":"Harput E, Boccalini C, Mathoux G, Prior JO, Testart N, Jreige M, et al. Mapping Alzheimer\u2019s disease heterogeneity with molecular imaging biomarkers. Eur J Clin Invest. 2026;56(1):e70163.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"3927_CR200","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00335-026-10199-3","volume":"37","author":"N Daskoulidou","year":"2026","unstructured":"Daskoulidou N, Nimmo J, Bright M, Yang Z, Nicholls LE, Morgan BP, et al. Complement in brain and eye disease: shared mechanisms, convergent pathologies, and common therapeutic opportunities. Mamm Genome. 2026;37(1):33.","journal-title":"Mamm Genome"},{"issue":"8","key":"3927_CR201","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.tips.2022.02.006","volume":"43","author":"WM Zelek","year":"2022","unstructured":"Zelek WM, Morgan BP. Targeting complement in neurodegeneration: challenges, risks, and strategies. Trends Pharmacol Sci. 2022;43(8):615\u201328.","journal-title":"Trends Pharmacol Sci"},{"key":"3927_CR202","doi-asserted-by":"crossref","unstructured":"Luciana Negro-Demontel AFM, Daniel S, Reich, Claudia Kemper. The complement system in neurodegenerative and inflammatory diseases of the central nervous system. Front Neurol 03 July 2024;15.","DOI":"10.3389\/fneur.2024.1396520"},{"issue":"4","key":"3927_CR203","doi-asserted-by":"publisher","first-page":"153089","DOI":"10.1016\/j.imbio.2025.153089","volume":"230","author":"WM Zelek","year":"2025","unstructured":"Zelek WM, Tenner AJ. Complement therapeutics in neurodegenerative diseases. Immunobiology. 2025;230(4):153089.","journal-title":"Immunobiology"},{"issue":"6","key":"3927_CR204","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","volume":"100","author":"Y-WW Alexandra Litvinchuk","year":"2018","unstructured":"Alexandra Litvinchuk Y-WW, Dan B, Swartzlander B, Zhang, Zhandong Liu HZ. Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer\u2019s Disease. Neuron. 2018;100(6):1337\u201353.","journal-title":"Neuron"},{"issue":"4","key":"3927_CR205","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy ER, Wang B, Wan Y-w, Chiu G, Cole A, Yin Z, et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Investig. 2020;130(4):1912\u201330.","journal-title":"J Clin Investig"},{"issue":"2","key":"3927_CR206","doi-asserted-by":"publisher","first-page":"e70497","DOI":"10.1002\/mco2.70497","volume":"7","author":"X Guo","year":"2026","unstructured":"Guo X, Liu H, Song YJ, Wang JH, Liu D, Zheng ZW, et al. Neuro-Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets. MedComm. 2026;7(2):e70497.","journal-title":"MedComm"},{"issue":"7772","key":"3927_CR207","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41586-019-1506-7","volume":"573","author":"RD Hodge","year":"2019","unstructured":"Hodge RD, Bakken TE, Miller JA, Smith KA, Barkan ER, Graybuck LT, et al. Conserved cell types with divergent features in human versus mouse cortex. Nature. 2019;573(7772):61\u20138.","journal-title":"Nature"},{"issue":"1","key":"3927_CR208","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah M, Menon V, Habib N, Taga MF, Ma Y, Yung CJ, et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat Commun. 2020;11(1):6129. https:\/\/doi.org\/10.1038\/s41467-020-19737-2","journal-title":"Nat Commun"},{"issue":"7416","key":"3927_CR209","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature11405","volume":"489","author":"MJ Hawrylycz","year":"2012","unstructured":"Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 2012;489(7416):391\u20139.","journal-title":"Nature"},{"key":"3927_CR210","doi-asserted-by":"publisher","first-page":"1403142","DOI":"10.3389\/fnagi.2024.1403142","volume":"16","author":"W Cao","year":"2024","unstructured":"Cao W. sickness and in health-Type I interferon and the brain. Front Aging Neurosci. 2024;16:1403142.","journal-title":"Front Aging Neurosci"},{"key":"3927_CR211","doi-asserted-by":"crossref","unstructured":"Carpanini SM, Torvell M, Morgan BP. Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System. Front Immunol. 2019;Volume 10\u20132019.","DOI":"10.3389\/fimmu.2019.00362"},{"issue":"2","key":"3927_CR212","doi-asserted-by":"publisher","first-page":"e200361","DOI":"10.1212\/NXI.0000000000200361","volume":"12","author":"J Oechtering","year":"2025","unstructured":"Oechtering J, Schaedelin SA, Stein K, Maleska Maceski A, Melie-Garcia L, Benkert P, et al. Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflammation. 2025;12(2):e200361.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"7","key":"3927_CR213","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.3390\/jcm14072527","volume":"14","author":"R-G Bogdan","year":"2025","unstructured":"Bogdan R-G, Anderco P, Ichim C, Cimpean A-M, Todor SB, Glaja-Iliescu M, et al. Atypical hemolytic uremic syndrome: A review of complement dysregulation, genetic susceptibility and multiorgan involvement. J Clin Med. 2025;14(7):2527.","journal-title":"J Clin Med"},{"issue":"7","key":"3927_CR214","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3345\/kjp.2015.58.7.239","volume":"58","author":"H Cho","year":"2015","unstructured":"Cho H. Complement regulation: physiology and disease relevance. Korean J Pediatr. 2015;58(7):239\u201344.","journal-title":"Korean J Pediatr"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03927-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03927-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03927-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:04:40Z","timestamp":1788872680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03927-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":214,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3927"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03927-8","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"During the preparation of this work, the author(s) used ChatGPT to improve readability and concise language. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":1,"name":"Ethics","label":"Declaration of generative AI in scientific writing","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"299"}}